We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Interpreting Perrigo (PRGO) International Revenue Trends
Read MoreHide Full Article
Did you analyze how Perrigo (PRGO - Free Report) fared in its international operations for the quarter ending June 2024? Given the widespread global presence of this drug company, scrutinizing the trends in international revenues becomes imperative to assess its financial strength and future growth possibilities.
The global economy today is deeply interlinked, making a company's engagement with international markets a critical factor in determining its financial success and growth path. It has become essential for investors to comprehend how much a company relies on these foreign markets, as this understanding reveals the firm's potential for consistent earnings, its capacity to harness different economic cycles, and its overall growth prospects.
Presence in international markets can act as a hedge against domestic economic downturns and provide access to faster-growing economies. However, this diversification also brings complexities due to currency fluctuations, geopolitical risks and differing market dynamics.
While delving into PRGO's performance for the past quarter, we observed some fascinating trends in the revenue from its foreign segments that are commonly modeled and observed by analysts on Wall Street.
The recent quarter saw the company's total revenue reaching $1.07 billion, marking a decline of 10.7% from the prior-year quarter. Next, we'll examine the breakdown of PRGO's revenue from abroad to comprehend the significance of its international presence.
A Closer Look at PRGO's Revenue Streams Abroad
Of the total revenue, $29.3 million came from All other countries during the last fiscal quarter, accounting for 2.8%. This represented a surprise of -24.04% as analysts had expected the region to contribute $38.58 million to the total revenue. In comparison, the region contributed $30.1 million, or 2.8%, and $31.6 million, or 2.7%, to total revenue in the previous and year-ago quarters, respectively.
Europe generated $408.4 million in revenues for the company in the last quarter, constituting 38.3% of the total. This represented a surprise of +2.47% compared to the $398.55 million projected by Wall Street analysts. Comparatively, in the previous quarter, Europe accounted for $419.7 million (38.8%), and in the year-ago quarter, it contributed $425.7 million (35.7%) to the total revenue.
International Market Revenue Projections
Wall Street analysts expect Perrigo to report $1.18 billion in total revenue for the current fiscal quarter, indicating an increase of 4.6% from the year-ago quarter. All other countries and Europe are expected to contribute 3.4% ($39.48 million) and 34.6% ($406.98 million) to the total revenue, respectively.
For the entire year, the company's total revenue is forecasted to be $4.61 billion, which is a reduction of 1% from the previous year. The revenue contributions from different regions are expected as follows: All other countries will contribute 3.2% ($148.74 million) and Europe 35.8% ($1.65 billion) to the total revenue.
Wrapping Up
Relying on global markets for revenues presents both prospects and challenges for Perrigo. Therefore, scrutinizing its international revenue trends is key to effectively forecasting the company's future outlook.
In an environment where global interconnections and geopolitical skirmishes are intensifying, Wall Street analysts keep a keen eye on these trends, particularly for firms with overseas operations, to adjust their earnings predictions. Moreover, a range of other aspects, including how a company fares in its home country, significantly affects these projections.
At Zacks, we place significant importance on a company's evolving earnings outlook. This is based on empirical evidence demonstrating its strong influence on a stock's short -term price movements. Invariably, there exists a positive relationship -- an upward revision in earnings estimates is typically mirrored by a rise in the stock price.
The Zacks Rank, our proprietary stock rating tool, comes with an externally validated impressive track record. It effectively utilizes shifts in earnings projections to act as a dependable barometer for forecasting short-term stock price trends.
Assessing Perrigo's Stock Price Movement in Recent Times
The stock has increased by 8.4% over the past month compared to the 2.9% fall of the Zacks S&P 500 composite. Meanwhile, the Zacks Medical sector, which includes Perrigo, has increased 3.2% during this time frame. Over the past three months, the company's shares have experienced a loss of 10.2% relative to the S&P 500's 5.9% increase. Throughout this period, the sector overall has witnessed a 5.1% increase.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Interpreting Perrigo (PRGO) International Revenue Trends
Did you analyze how Perrigo (PRGO - Free Report) fared in its international operations for the quarter ending June 2024? Given the widespread global presence of this drug company, scrutinizing the trends in international revenues becomes imperative to assess its financial strength and future growth possibilities.
The global economy today is deeply interlinked, making a company's engagement with international markets a critical factor in determining its financial success and growth path. It has become essential for investors to comprehend how much a company relies on these foreign markets, as this understanding reveals the firm's potential for consistent earnings, its capacity to harness different economic cycles, and its overall growth prospects.
Presence in international markets can act as a hedge against domestic economic downturns and provide access to faster-growing economies. However, this diversification also brings complexities due to currency fluctuations, geopolitical risks and differing market dynamics.
While delving into PRGO's performance for the past quarter, we observed some fascinating trends in the revenue from its foreign segments that are commonly modeled and observed by analysts on Wall Street.
The recent quarter saw the company's total revenue reaching $1.07 billion, marking a decline of 10.7% from the prior-year quarter. Next, we'll examine the breakdown of PRGO's revenue from abroad to comprehend the significance of its international presence.
A Closer Look at PRGO's Revenue Streams Abroad
Of the total revenue, $29.3 million came from All other countries during the last fiscal quarter, accounting for 2.8%. This represented a surprise of -24.04% as analysts had expected the region to contribute $38.58 million to the total revenue. In comparison, the region contributed $30.1 million, or 2.8%, and $31.6 million, or 2.7%, to total revenue in the previous and year-ago quarters, respectively.
Europe generated $408.4 million in revenues for the company in the last quarter, constituting 38.3% of the total. This represented a surprise of +2.47% compared to the $398.55 million projected by Wall Street analysts. Comparatively, in the previous quarter, Europe accounted for $419.7 million (38.8%), and in the year-ago quarter, it contributed $425.7 million (35.7%) to the total revenue.
International Market Revenue Projections
Wall Street analysts expect Perrigo to report $1.18 billion in total revenue for the current fiscal quarter, indicating an increase of 4.6% from the year-ago quarter. All other countries and Europe are expected to contribute 3.4% ($39.48 million) and 34.6% ($406.98 million) to the total revenue, respectively.For the entire year, the company's total revenue is forecasted to be $4.61 billion, which is a reduction of 1% from the previous year. The revenue contributions from different regions are expected as follows: All other countries will contribute 3.2% ($148.74 million) and Europe 35.8% ($1.65 billion) to the total revenue.
Wrapping Up
Relying on global markets for revenues presents both prospects and challenges for Perrigo. Therefore, scrutinizing its international revenue trends is key to effectively forecasting the company's future outlook.In an environment where global interconnections and geopolitical skirmishes are intensifying, Wall Street analysts keep a keen eye on these trends, particularly for firms with overseas operations, to adjust their earnings predictions. Moreover, a range of other aspects, including how a company fares in its home country, significantly affects these projections.
At Zacks, we place significant importance on a company's evolving earnings outlook. This is based on empirical evidence demonstrating its strong influence on a stock's short -term price movements. Invariably, there exists a positive relationship -- an upward revision in earnings estimates is typically mirrored by a rise in the stock price.
The Zacks Rank, our proprietary stock rating tool, comes with an externally validated impressive track record. It effectively utilizes shifts in earnings projections to act as a dependable barometer for forecasting short-term stock price trends.
At present, Perrigo holds a Zacks Rank #3 (Hold). This ranking implies that its near-term performance might mirror the overall market movement. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Assessing Perrigo's Stock Price Movement in Recent Times
The stock has increased by 8.4% over the past month compared to the 2.9% fall of the Zacks S&P 500 composite. Meanwhile, the Zacks Medical sector, which includes Perrigo, has increased 3.2% during this time frame. Over the past three months, the company's shares have experienced a loss of 10.2% relative to the S&P 500's 5.9% increase. Throughout this period, the sector overall has witnessed a 5.1% increase.